Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	ENHERTU
Active Ingredient:	Trastuzumab deruxtecan 100mg
Dosage Form:	Powder for concentrate for infusion
New Zealand Sponsor:	AstraZeneca Limited
Manufacturer:	Baxter Oncology GmbH, Halle-Kunsebeck Westfalen, Germany

*Product:*	Noradrenaline BNM
Active Ingredient:	Noradrenaline acid tartrate 2mg/mL
Dosage Form:	Concentrate for injection
New Zealand Sponsor:	Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer:	Sintetica SA, Mendrisio, Switzerland

Dated this 12th day of August 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule